Differential Expression of Vascular Endothelial Growth Factor (VEGF), Endocrine Gland Derived-VEGF, and VEGF Receptors in Human Placentas from Normal and Preeclamptic Pregnancies

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2484-2490

  Chung, Jin Young ^a   Song, Yang ^a   Wang, Yuping ^c   Magness, Ronald R ^a,b   Zheng, Jing ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; MESSENGER RNA; NEUROPILIN 1; NEUROPILIN 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PLACENTA; PLACENTA CIRCULATION; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST; VASODILATATION; WESTERN BLOTTING;

CASE-CONTROL STUDIES; FEMALE; HUMANS; NEUROPILIN-1; NEUROPILIN-2; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MAMMALIA;

EID: 2442519102     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031580     Document Type: Article

References (43)

1. August P, Lindheimer MD 1995 Pathophysiology of preeclampsia. In: Laragh JL, Brenner BM, eds. Hypertension. 2nd ed. New York: Raven Press; 2407-2426
2. Page NM 2002 The endocrinology of pre-eclampsia. Clin Endocrinol (Oxf) 57:413-423
3. Roberts JM, Lain KY 2002 Recent insights into the pathogenesis of pre-eclampsia. Placenta 23:359-372
4. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
5. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439
6. Poltorak Z, Cohen T, Neufeld G 2000 The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases. Herz 25:126-129
7. Cheung CY, Singh M, Ebaugh MJ, Brace RA 1995 Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 173:753-759
8. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW 1991 The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814
9. Lei J, Jiang A, Pei D 1998 Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim Biophys Acta 1443:400-406
10. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N 1996 The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788-7795
11. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar W, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT 1999 Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5:495-502
12. Halder JB, Zhao X, Soker S, Paria BC, Klagsbrun M, Das SK, Dey SK 2000 Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 26:213-224
13. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA 2001 Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220:112-121
14. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N 2001 Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877-884
15. Ferrara N, Gerber HP, LeCouter J 2003 The biology of VEGF and its receptors. Nat Med 9:669-676
16. Gille H, Kowalski J, Yu L, Chen H, Pisabarro MT, Davis-Smyth T, Ferrara N 2000 A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. EMBO J 19:4064-4073
17. Zeng H, Dvorak HF, Mukhopadhyay D 2001 Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 276:26969-26979
18. Fong GH, Rossant J, Gertsenstein M, Breitman ML 1995 Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
19. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC 1995 Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
20. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M 1998 Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745
21. Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G 2000 Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 275:18040-18045
22. Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G 2001 Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem 276:18688-18694
23. Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, Tashiro F, Niwa H, Miyazaki JJ, Hirota S, Kitamura Y, Kitsukawa T, Fujisawa H, Klagsbrun K, Mori M 2002 Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 99:3657-3662
24. Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M 2002 VEGF165 mediates formation of complexes containing VEGFR-2 and neuropflin-1 that enhance VEGF165-receptor binding. J Cell Biochem 85:357-368
25. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FK Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
26. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK 1996 VEGF mRNA levels in placentae from pregnancies complicated by preeclampsia. Br J Obstet Gynaecol 103:1191-1196
27. Trollmann R, Amann K, Schoof E, Beinder E, Wenzel D, Rascher W, Dotsch J 2003 Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. Am J Obstet Gynecol 188:517-523
28. Ranheim T, Staff AC, Henriksen T 2001 VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery. Acta Obstet Gynecol Scand 80:93-98
29. Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA, Milbrandt J 2000 EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 275:38524-38531
30. Zheng J, Bird IM, Melsaether AN, Magness RR 1999 Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140:1399-1407
31. Tsoi SCM, Wen YX, Chung JY, Chen DB, Magness RR, Zheng J 2002 Co-expression of vascular endothelial growth factor and neurophilin-1 in ovine feto-placental artery endothelial cells. Mol Cell Endocrinol 196:95-106
32. Cheng SY, Nagane M, Huang HS, Cavenee WK 1997 Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA 94:12081-12087
33. Ahmed A, Dunk C, Kniss D, Wilkes M 1997 Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791
34. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I, and Baker P 1999 VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 79:1101-1111
35. El-Salahy EM, Ahmed MI, El-Gharieb A, Tawfik H 2001 New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females. Clin Biochem 34:323-329
36. Bosio PM, Wheeler T, Anthony F, Conroy R, O'herlihy C, McKenna P 2001 Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 184:146-152
37. Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, Halmesmaki E 2000 Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol 95:353-357
38. Koga K, Osuga Y, Yashina O, Hirota Y, Ruimeng Y, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y 2003 Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 88:2348-2351
39. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T 1995 Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12:235-243
40. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS 1997 Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18:657-665
41. Athanassiades A, Hamilton GS, Lala PK 1998 Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillouus trophoblast. Biol Reprod 59:643-654
42. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ 2002 Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405-1423
43. Walsh SW, Wang Y 1995 Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 80:1888-1893